Northern RNA is excited to share the news of our new collaboration with Galenvs Sciences, a partnership set to advance the future of synthetic RNA manufacturing in Canada! This collaboration is a big step forward in expanding our capabilities across the therapeutic oligonucleotide space, including siRNA, sgRNA, ASO, and PMO manufacturing technologies.
Working closely with Galenvs Sciences, our team of industry experts is committed to driving innovation and setting new standards in RNA therapeutics. Together, we are laying the groundwork for groundbreaking advancements in RNA manufacturing and bringing cutting-edge RNA solutions to the forefront of the global healthcare landscape.
This collaboration is more than just a partnership—it’s a catalyst for progress in the rapidly evolving field of synthetic RNA, addressing the growing demand for therapeutic innovation. Together, we are laying the foundation for breakthroughs that will accelerate the development of new treatments, including potential therapies for rare diseases, cancer, and other complex health challenges.
We are eager to see what our combined expertise will achieve as we push the boundaries of synthetic RNA technologies, accelerate therapeutic advancements, and strengthen the RNA biomanufacturing landscape across the country.
Linkden Post: Northern RNA Announces Exciting Collaboration!